-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Codiak BioSciences, Inc. quarterly/annual Revenues history and growth rate from Q3 2019 to Q3 2022.
- Codiak BioSciences, Inc. Revenues for the quarter ending September 30, 2022 was $522K, a 54.9% decline year-over-year.
- Codiak BioSciences, Inc. Revenues for the twelve months ending September 30, 2022 was $34.1M, a 102% increase year-over-year.
- Codiak BioSciences, Inc. annual Revenues for 2021 was $22.9M, a 687% increase from 2020.
- Codiak BioSciences, Inc. annual Revenues for 2020 was $2.92M, a 651% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)